Posts by Sandra Ansanay-Alex
Venture Leaders Medtech Team 2022
Ten startups have been chosen by a jury of investors as the Swiss National Startup Team for Venture Leaders Medtech 2022. The designated entrepreneurs fly to Boston for a one-week roadshow in June 2022 to accelerate their expansion into the US market and build an exceptional business network through meetings with top-notch investors…
Read MoreCafé Innovation | HUG | 5 April
Innovation Café, Tuesday 5 April , 2022 from 12:45 to 1:45 pm. Theme: “Personalized cancer immunotherapy in Geneva: from the laboratory to Phase II, the journey of MaxiVAX”. Presented by Pr Nicolas Mach, Oncology Department of the HUG & Faculty of Medicine of the University of Geneva, co-founder of the startup MaxiVAX. Where: Centre de…
Read MoreA MEG plateform at Campus Biotech in 2022
A new device for brain research at the Campus Biotech Next summer, the Human Neuroscience Platform (HNP) at Campus Biotech will acquire and install a new Magnetoencephalography (MEG). The new MEGIN Triux neo will integrate the already existing MEEG-BCI MRI facility. Magnetoencephalography (MEG) is a non-invasive imaging technique for investigating human brain activity. Dr…
Read MoreCompletely locked-in man uses brain-computer interface to communicate
Researchers at the Wyss Center Geneva created a device and a computer program to decode brain signals Completely paralyzed and unable to speak, a 30-year-old man was able to speak with its caregivers and his family. He even managed to ask his 4-year-old son : “Do you want to watch Disney’s Robin Hood with…
Read MoreINTERVIEW – Ana Pinto
🔺 Why Western Switzerland🇨🇭 is so attractive to life sciences companies? Ana Pinto, Business Partner at the Service de l’Économie du Canton de Neuchâtel has the answer.
Read MoreSwiss Biotech Day
The Swiss Biotech Day is organised from 24 to 25 April 2023 at the Congress Center Basel
Read MoreParithera raises CHF 100 000 from FIT
The Foundation for Technological Innovation (FIT) has granted a CHF 100’000 Tech Seed loan to Parithera and its ExTrace Dx solution for cancer treatment. 90% of patients die from cancer because of treatment resistance. Parithera developed an integrated in-vitro diagnostic solution for cancer treatments’ response monitoring single blood draws to better understand diagnostics and…
Read MoreNagi Bioscience won a € 2,5 million grant from the EIC Accelerator
The company revolutionizes pre-clinical testing with its pioneer Organism-on-Chip technology Nagi Bioscience has been bestowed the prestigious and highly selective EIC Accelerator Grant supporting breakthrough innovation in Europe, funded by the Swiss State Secretariat for Education, Research and Innovation (SERI) for Swiss Startups, for its pioneer Organism-on-Chip technology. The EPFL spin-off uses C. elegans, a small worm…
Read MoreMedical devices for Ukraine
The Ukraine Embassy launches an appeal for donations Collection points in Switzerland The war in Ukraine has thrown millions of people into exile and the health situation there is dramatic. There is a shortage of medical devices needed for basic care, transport and treatment of the wounded, and intensive care. In this context, the…
Read MoreSEED Biosciences raises CHF 400 000
The EPFL spin-off has developed a pipetting robot that can dispense individual cells one by one. The device, called Dispencell, saves precious time – up to several weeks – for life science researchers, and accelerates research in the fields of pharmaceuticals, cancer or personalized medicine. Today, finding the perfect cure for every cancer patient…
Read More